Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
34.31
-0.06 (-0.17%)
Feb 11, 2026, 4:00 PM EST - Market closed
Teva Pharmaceutical Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$36.75
Upside
+7.11%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $36 → $45 | Strong Buy | Maintains | $36 → $45 | +31.16% | Feb 9, 2026 |
| Barclays | Barclays | Buy Maintains $35 → $38 | Buy | Maintains | $35 → $38 | +10.75% | Jan 30, 2026 |
| Scotiabank | Scotiabank | Buy Maintains $35 → $40 | Buy | Maintains | $35 → $40 | +16.58% | Jan 29, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $36 → $38 | Strong Buy | Maintains | $36 → $38 | +10.75% | Jan 29, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $29 → $40 | Strong Buy | Maintains | $29 → $40 | +16.58% | Jan 6, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $30 → $40 | Buy | Maintains | $30 → $40 | +16.58% | Dec 22, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $31 → $35 | Strong Buy | Maintains | $31 → $35 | +2.01% | Dec 19, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $28 → $35 | Buy | Maintains | $28 → $35 | +2.01% | Dec 16, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $29 → $32 | Strong Buy | Maintains | $29 → $32 | -6.73% | Dec 9, 2025 |
| Barclays | Barclays | Buy Initiates $35 | Buy | Initiates | $35 | +2.01% | Dec 9, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $28 → $31 | Strong Buy | Maintains | $28 → $31 | -9.65% | Dec 8, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $35 | Buy | Initiates | $35 | +2.01% | Dec 5, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $26 → $28 | Buy | Maintains | $26 → $28 | -18.39% | Nov 6, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $23 → $26 | Buy | Maintains | $23 → $26 | -24.22% | Oct 3, 2025 |
| UBS | UBS | Strong Buy Maintains $23 → $26 | Strong Buy | Maintains | $23 → $26 | -24.22% | Sep 24, 2025 |
| UBS | UBS | Strong Buy Maintains $24 → $23 | Strong Buy | Maintains | $24 → $23 | -32.96% | Jun 26, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.